CAS 129722-12-9

General Information

Aripiprazole is a quinoline derivate and atypical antipsychotic agent. Aripiprazole is indicated for managing symptoms of schizophrenia and of acute manic and mixed episodes associated with bipolar I disorders in adults.

Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A receptors, as well as potent antagonistic activity on serotonin 5-HT2A receptors. Aripiprazole stabilizes dopamine and serotonin activity in the limbic and cortical system.

About the API

Technology Synthetic Organic Chemistry
Molecular Formula C23H27Cl2N3O2
Therapeutic category Neurology-Psychiatry
Available formulations Oral Liquid Oral Solid
Regulations CEP Flag CEP EU DMF Flag EU DMF Japan DMF Flag Japan DMF Other Flag Other US DMF Flag US DMF